Biocryst Pharmaceuticals Inc (BCRX)

Operating Cash Flow (Statement)

$359.87M

TTM · Period ending: · USD

BCRX logo

BCRX Operating Cash Flow (Statement)

Latest reported$359.87M
BCRX TTM Cash from Operations (-$6.50M → $359.87M)
High-resolution chart · PNG

BCRX operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biocryst Pharmaceuticals Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
359,866,000
296,826,000
331,445,000
50,196,000
16,817,000
-25,853,000
-52,020,000
-55,725,000
-83,867,000
-101,313,000
-95,141,000
-110,072,000
-122,619,000
-131,562,000
-161,850,000
-170,460,000
-161,292,000
-158,946,000
-142,157,000
-154,337,000
-169,316,000
-174,946,000
-137,216,000
-103,025,000
-92,407,000
-85,867,000
-89,584,000
-103,121,000
-110,516,000
-99,910,000
-92,565,000
-79,099,000
-56,497,000
-52,269,000
-41,143,000
-36,478,000
-41,606,000
-43,123,000
-53,438,000
-62,412,000
-57,514,000
-28,232,000
-13,116,000
-12,178,000
-8,118,000
-33,318,000
-38,551,000
-29,176,000
-28,498,000
-24,291,000
-26,530,000
-29,045,000
-32,900,000
-36,347,000
-37,397,000
-34,351,000
-33,043,000
-30,172,000
-32,251,000
-34,086,221
-32,845,221
-37,693,221
-28,554,221
-13,099,470
-8,997,470
-12,346,470
-16,218,470
-30,391,820
-31,185,820
-25,432,820
-20,873,820
-32,340,799
-31,161,799
-26,101,799
-24,997,799
-23,869,315
-32,139,315
-44,955,315
-15,211,315
-6,088,157
781,843
8,537,843
-23,346,157
-23,009,335
-20,732,335
-19,469,335
-18,151,335
-15,441,000
-14,605,000
-12,758,000
-11,196,000
-10,740,055
-11,075,055
-12,980,055
-16,364,055
-17,394,486
-16,214,486
-13,968,486
-10,158,486
-8,657,640
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.